Velarion Records
Free. Unsubscribe any time.

Syndax Pharmaceuticals Inc (SNDX)

Syndax Pharmaceuticals Inc filed 5 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 8 transactions and 320,611 shares. 5 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 8 results prints are on file in the same window.

What stands out

Trades in Syndax Pharmaceuticals Inc 8

Adoption dates in Syndax Pharmaceuticals Inc 0

Results prints in Syndax Pharmaceuticals Inc 8

Trades before a print in Syndax Pharmaceuticals Inc 0

Interval to Syndax Pharmaceuticals Inc’s next reported results date

How the interval and sources are counted →

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.